Hanna Lydia, Rodway Alexander D, Garcha Puneet, Maynard Luci, Sivayogi Janane, Schlager Oliver, Madaric Juraj, Boc Vinko, Busch Lucas, Whyte Martin B, Skene Simon S, Harris Jenny, Heiss Christian
Department of Surgery and Cancer, Imperial College London, London, UK.
Vascular Medicine Department, Surrey and Sussex Healthcare NHS Trust, Redhill, UK.
EClinicalMedicine. 2024 Sep 5;75:102788. doi: 10.1016/j.eclinm.2024.102788. eCollection 2024 Sep.
Timely and economic provision of revascularisation procedures is a major healthcare need. We aimed to examine the safety and efficacy of daycase-based lower extremity endovascular revascularisation procedures in patients with peripheral artery disease.
In this systematic review and meta-analysis, we searched MEDLINE and Embase for studies from Jan 01, 2000 through Apr 01, 2024 reporting complications of lower limb endovascular revascularisation procedures with same-day discharge. Eligibility-criteria, complications, and patient characteristics were extracted, methodological quality assessed (adapted Newcastle-Ottawa Scale), and meta-analyses of complications and technical success performed to provide pooled estimates. This study is registered with PROSPERO, CRD42022316466.
Thirty observational studies (17 retrospective, 13 prospective) and 1 RCT reported 2427 minor and 653 major complications after 99,600 daycase procedures (93,344 patients). Eighteen studies reported daycase eligibility-criteria including 'responsible adult companion' (78%), 'proximity to hospital', and 'telephone availability' and excluding unstable and severe co-morbidities, offset coagulation, and severe chronic kidney disease. Pooled incidences of minor (4.7% [95% CI 3.8-5.6%], = 96%) and major (0.64% [95% CI 0.48-0.79%], = 46%) complications were low and technical success high (93% [95% CI 91-96%], = 97%). Most complications were related to the puncture site. Pooled conversion-to-hospitalisation rates and re-admission after discharge were 1.6% (95% CI 1.1-2.2%, = 82%) and 0.11% (95% CI 0.095-0.23%, = 97%), respectively. Meta-regression identified that minor complications decreased since 2000. Male sex and coronary artery disease were associated with more frequent, and higher age and closure device use with less minor complications. Diabetes mellitus and chronic kidney disease were associated with less major complications. Six studies reported complication rates both in daycases and inpatients and there was no significant difference (-0.8% [95% CI -1.9 to 0.3%]).
After careful evaluation of eligibility, lower limb angioplasty can be performed safely with high technical success in a daycase setting. Most complications arise from the puncture site and not the procedure itself highlighting the importance of optimal access site management. The heterogeneity between studies warrants standardised monitoring of complications and outcomes.
European Partnership on Metrology, co-financed from European Union's Horizon Europe Research and Innovation Programme and UK Research and Innovation, and Medical Research Council.
及时且经济地提供血管重建手术是一项重大的医疗需求。我们旨在研究基于日间手术的下肢血管腔内血管重建手术在周围动脉疾病患者中的安全性和有效性。
在这项系统评价和荟萃分析中,我们检索了MEDLINE和Embase数据库,以查找2000年1月1日至2024年4月1日期间报告同日出院的下肢血管腔内血管重建手术并发症的研究。提取纳入标准、并发症和患者特征,评估方法学质量(采用改良的纽卡斯尔-渥太华量表),并对并发症和技术成功率进行荟萃分析以提供合并估计值。本研究已在PROSPERO注册,注册号为CRD42022316466。
30项观察性研究(17项回顾性研究,13项前瞻性研究)和1项随机对照试验报告了99,600例日间手术(93,344例患者)后发生的2427例轻微并发症和653例严重并发症。18项研究报告了日间手术的纳入标准,包括“有责任的成年陪同人员”(78%)、“距离医院较近”和“可接通电话”,并排除不稳定和严重的合并症、凝血功能异常以及严重的慢性肾脏病。轻微并发症(4.7% [95%置信区间3.8 - 5.6%],I² = 96%)和严重并发症(0.64% [95%置信区间0.48 - 0.79%],I² = 46%)的合并发生率较低,技术成功率较高(93% [95%置信区间91 - 96%],I² = 97%)。大多数并发症与穿刺部位有关。合并的转为住院率和出院后再入院率分别为1.6%(95%置信区间1.1 - 2.2%,I² = 82%)和0.11%(95%置信区间0.095 - 0.23%,I² = 97%)。荟萃回归分析表明,自2000年以来轻微并发症有所减少。男性和冠状动脉疾病与更频繁的轻微并发症相关,而年龄较大和使用闭合装置与较少的轻微并发症相关。糖尿病和慢性肾脏病与较少的严重并发症相关。6项研究报告了日间手术和住院患者的并发症发生率,两者无显著差异(-0.8% [95%置信区间 -1.9至0.3%])。
在仔细评估纳入标准后,下肢血管成形术可在日间手术环境中安全地进行,技术成功率较高。大多数并发症源于穿刺部位而非手术本身,这突出了优化穿刺部位管理的重要性。研究之间的异质性需要对并发症和结果进行标准化监测。
欧洲计量伙伴关系,由欧盟“地平线欧洲”研究与创新计划、英国研究与创新以及医学研究理事会共同资助。